BioSpace News Archive

As the COVID-19 pandemic continues with surges in the U.S. in unvaccinated people, biopharma companies are still working on new vaccines and therapies against the disease.

In a patent infringement lawsuit filed against Eli Lilly, Teva Pharmaceuticals won three and lost six patents. The patent lawsuit was over Teva’s Ajovy (fremanezumab-vfrm) to prevent migraines.

If you are in a hybrid work environment, you might be finding it difficult to work between office and home. Here are a few tips to help optimize your work.

Basilea Pharmaceutica Ltd. announced that it has been awarded an additional USD 4.3 million of non-dilutive funding by the Biomedical Advanced Research and Development Agency, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, in the context of the existing contract to support the phase 3 program of Basilea’s antibiotic ceftobiprole.

Sino Biological, Inc., a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext under the stock abbreviation Sino Biological and stock code 301047.

Urethral bulking is used to treat urinary incontinence. It involves injecting material, such as collagen, around the urethra.

The demand within the global market for splenomegaly therapeutics has been rising on account of advancements in the field of spleen-care.

The two main types of materials of contact lenses are soft and hard or rigid. Scleral lens is a type of hard or rigid material contact lens, and it’s generally larger in diameter than other contact lenses.

More than 7000 types of rare diseases affect more than 30 million people in the U.S. alone. Approximately 80% of the rare diseases are found to be genetic.

The increasing prevalence of cancer cases and the advent of the latest technology to combat various cancer types emerge as a prime factor augmenting the growth of the global radiotherapy market.